Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ATP1B1-NRG1 fusion
i
Other names:
ATP1B1, ATPase Na+/K+ Transporting Subunit Beta 1, Sodium/Potassium-Transporting ATPase Subunit Beta-1, Sodium-Potassium ATPase Subunit Beta 1 (Non-Catalytic), ATPase, Na+/K+ Transporting, Beta 1 Polypeptide, Sodium Pump Subunit Beta-1, ATP1B, Sodium/Potassium-Transporting ATPase Beta-1 Chain, Sodium/Potassium-Dependent ATPase Beta-1 Subunit, Sodium/Potassium-Dependent ATPase Subunit Beta-1, Beta 1-Subunit Of Na(+),K(+)-ATPase Na, K-ATPase Beta-1 Polypeptide, Adenosinetriphosphatase, NRG1, GGF,
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3084
;
481
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
NRG1 overexpression (4)
NRG1 overexpression + ERBB3 expression (1)
NRG1 overexpression (4)
NRG1 overexpression + ERBB3 expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ATP1B1-NRG1 fusion
Pancreatic Cancer
ATP1B1-NRG1 fusion
Pancreatic Cancer
zenocutuzumab-zbco
Sensitive: C3 – Early Trials
zenocutuzumab-zbco
Sensitive
:
C3
zenocutuzumab-zbco
Sensitive: C3 – Early Trials
zenocutuzumab-zbco
Sensitive
:
C3
ATP1B1-NRG1 fusion
Cholangiocarcinoma
ATP1B1-NRG1 fusion
Cholangiocarcinoma
afatinib
Resistant: C4 – Case Studies
afatinib
Resistant
:
C4
afatinib
Resistant: C4 – Case Studies
afatinib
Resistant
:
C4
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
afatinib
Sensitive: C4 – Case Studies
afatinib
Sensitive
:
C4
afatinib
Sensitive: C4 – Case Studies
afatinib
Sensitive
:
C4
ATP1B1-NRG1 fusion
Pancreatic Cancer
ATP1B1-NRG1 fusion
Pancreatic Cancer
afatinib
Sensitive: C4 – Case Studies
afatinib
Sensitive
:
C4
afatinib
Sensitive: C4 – Case Studies
afatinib
Sensitive
:
C4
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
ATP1B1-NRG1 fusion
Pancreatic Ductal Adenocarcinoma
MM-121
Sensitive: D – Preclinical
MM-121
Sensitive
:
D
MM-121
Sensitive: D – Preclinical
MM-121
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.